• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN GOOSENECK SNARE; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN GOOSENECK SNARE; CATHETER, PERCUTANEOUS Back to Search Results
Device Problem Use of Device Problem (1670)
Patient Problems Stroke/CVA (1770); Rupture (2208)
Event Date 06/26/2019
Event Type  Injury  
Manufacturer Narrative
Event date: date of article publication (i.E.Event date is literature article published date) homemade fenestrated stent-grafts for complete endovascular repair of aortic arch dissections journal of endovascular therapy (2019) vol.26(5) 645¿651 10.1177/1526602819858578.If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported in the literature article, homemade fenestrated stent-grafts for complete endovascular repair of aortic arch dissect ions, that 35 patients underwent homemade single- and double-fenestrated stent-graft repair of aortic arch dissections from july 204 to september 2018.Valiant stent-grafts were modified by having a portion of the device unsheathed to expose the area that was to be modified.Fenestrations were marked and fashioned on the stent-graft according to the measurements obtained.A size 11 blade was used to create a proximal large fenestration, where at least 5 mm of fabric was used between the proximal fenestration and the proximal edge of the stent-graft fabric.A cautery device was used to carefully burn the dacron fabric to create the lsa fenestration.A radiopaque nitinol wire from the loop of the snare from a amplatz goose neck snare was used to reinforce the seal around the opening and mark its position, where it was sewn to the edge of the lsa fenestration.The homemade device delivery system was positioned superiorly on entering the arch of the patient.The stent-graft fenestration marker was positioned on the outer curve of the thoracic aorta.The fenestration was oriented towards the lsa by aligning the radiopaque marker with the target vessel.When the marker was misaligned, the stent-graft was pulled back into the descending thoracic aorta, rotated to adjust the position of the fenestration, and reintroduced into the aortic arch.A 7-f sheath was place retrogradely through the left branchial artery access to the ostium of the lsa.The mean blood pressure was then lowered to ~80 mm hg and the stent-graft was partially deployed.A 0.035" guidewire from the branchial access was advanced through the fenestration into the stent-graft lumen.The sheath was then advanced through the fenestration into the stent-graft lumen.The thoracic stent-graft was then fully deployed.A 8- to 10- non-medtronic balloon-expandable covered stent was deployed protruding ~ 5 mm into the aortic stent-graft lumen, with the remaining length in the lsa.The instrastent-graft portion of the covered stent was then flared using a 14- by 20- mm balloon introduced from the branchial access.In two double-fenestrated stent-grafts, lsa catheterization failed and surgical revascularization and stent-graft coverage of the fenestration was required.Three patients with partial coverage of the lcca required placement of a covered stent.After 30 days, one patient with a single-fenestrated stent-graft repair had a stoke without permanent sequelae.Type ii endoleaks required distal extension of the covered stent in the lsa with further covered stent.Two patients with ruptured dissected aortic arch aneurysms died despite successful endovascular exclusion.One late type i endoleak in a patient treated using a single-fenestrated stent-graft was treated by additional proximal fenestrated stent-graft placement, necessitating lsa coverage and surgical revascularization.An additional patient died 4 months after the endovascular procedure of a nonaortic cause.All supra-aortic trunks were patent.Long-term antiplatelet therapy was systematically used in cohort of patients.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GOOSENECK SNARE
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key9502394
MDR Text Key173191346
Report Number2183870-2019-00596
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K972511
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Physician
Type of Report Initial
Report Date 12/20/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/16/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
-
-